Breaking News Instant updates and real-time market news.

SITM

SiTime

$57.98 /

+1.07 (+1.88%)

, AAPL

Apple

$440.11 /

+1.31 (+0.30%)

07:05
08/06/20
08/06
07:05
08/06/20
07:05

SiTime price target raised to $75 from $50 at Barclays

Barclays analyst Blayne Curtis raised the firm's price target on SiTime (SITM) to $75 from $50 and keeps an Overweight rating on the shares. The company reported a "strong beat and raise" but the biggest news was the new design win at Apple (AAPL) and the entrance into the clock market, Curtis tells investors in a research note. The move into clocks won't bring revenue for a couple years but it opens a new total addressable market which will expand as additional products are launched, says the analyst. Curtis believes SiTime's report "checks all of the boxes" with both near-term strength and prove points the company can continue to penetrate the "large" timing market.

SITM

SiTime

$57.98 /

+1.07 (+1.88%)

AAPL

Apple

$440.11 /

+1.31 (+0.30%)

  • 01

    Sep

  • 21

    Nov

  • 12

    Jun

SITM SiTime
$57.98 /

+1.07 (+1.88%)

07/07/20 Needham
SiTime price target raised to $55 from $40 at Needham
06/30/20
Fly Intel: Top five analyst initiations
06/30/20 William Blair
SiTime initiated with an Outperform at William Blair
06/17/20 Barclays
SiTime price target raised to $50 from $24 at Barclays
AAPL Apple
$440.11 /

+1.31 (+0.30%)

08/05/20
Fly Intel: Top five analyst downgrades
08/05/20 Wells Fargo
Apple price target raised to $485 from $450 at Wells Fargo
08/05/20 Bernstein
2021 could be 'big year' for Apple iPhones, says Bernstein
08/05/20 BofA
BofA downgrades Apple to Neutral, ups price target to $470

TODAY'S FREE FLY STORIES

Upgrade
Henkel upgraded to Buy from Neutral at Goldman Sachs » 19:42
09/28/20
09/28
19:42
09/28/20
19:42
HENKY

Henkel

$0.00 /

+ (+0.00%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HENKY Henkel
$0.00 /

+ (+0.00%)

09/08/20 Morgan Stanley
Henkel price target raised to EUR 74 from EUR 69 at Morgan Stanley
08/26/20 RBC Capital
Henkel price target raised to EUR 99 from EUR 98 at RBC Capital
08/18/20 Barclays
Henkel price target raised to EUR 89 from EUR 88 at Barclays
08/11/20 Berenberg
Henkel price target raised to EUR 85 from EUR 84 at Berenberg
HENKY Henkel
$0.00 /

+ (+0.00%)

Upgrade
L'Oreal upgraded to Buy from Neutral at Goldman Sachs » 19:40
09/28/20
09/28
19:40
09/28/20
19:40
LRLCY

L'Oreal

$0.00 /

+ (+0.00%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LRLCY L'Oreal
$0.00 /

+ (+0.00%)

LRLCY L'Oreal
$0.00 /

+ (+0.00%)

09/17/20 Bryan Garnier
L'Oreal upgraded to Conviction Buy from Neutral at Bryan Garnier
08/20/20 Argus
L'Oreal price target raised to $76 from $68 at Argus
08/18/20 Barclays
L'Oreal price target raised to EUR 250 from EUR 236 at Barclays
08/18/20 RBC Capital
Estee Lauder price target raised to $194 from $173 at RBC Capital
LRLCY L'Oreal
$0.00 /

+ (+0.00%)

LRLCY L'Oreal
$0.00 /

+ (+0.00%)

Hot Stocks
Apollo Endosurgery discontinues furlough program » 19:34
09/28/20
09/28
19:34
09/28/20
19:34
APEN

Apollo Endosurgery

$1.38 /

-0.04 (-2.82%)

On September 23, 2020,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
APEN Apollo Endosurgery
$1.38 /

-0.04 (-2.82%)

APEN Apollo Endosurgery
$1.38 /

-0.04 (-2.82%)

04/28/20 Piper Sandler
Apollo Endosurgery downgraded to Neutral from Overweight at Piper Sandler
03/27/20 Piper Sandler
Apollo Endosurgery price target lowered to $4.50 from $5.50 at Piper Sandler
11/18/19 Piper Jaffray
Apollo Endosurgery transferred with an Overweight rating at Piper Jaffray
11/18/19 Piper Jaffray
Apollo Endosurgery transferred with an Overweight rating at Piper Jaffray
APEN Apollo Endosurgery
$1.38 /

-0.04 (-2.82%)

Earnings
Apollo Endosurgery sees Q3 revenue above Q3 of last year » 19:32
09/28/20
09/28
19:32
09/28/20
19:32
APEN

Apollo Endosurgery

$1.38 /

-0.04 (-2.82%)

In a regulatory 8K filing…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
APEN Apollo Endosurgery
$1.38 /

-0.04 (-2.82%)

APEN Apollo Endosurgery
$1.38 /

-0.04 (-2.82%)

04/28/20 Piper Sandler
Apollo Endosurgery downgraded to Neutral from Overweight at Piper Sandler
03/27/20 Piper Sandler
Apollo Endosurgery price target lowered to $4.50 from $5.50 at Piper Sandler
11/18/19 Piper Jaffray
Apollo Endosurgery transferred with an Overweight rating at Piper Jaffray
11/18/19 Piper Jaffray
Apollo Endosurgery transferred with an Overweight rating at Piper Jaffray
Hot Stocks
Ascendis Pharma announces 6-month data from ph.2 study of TransCon PTH » 19:07
09/28/20
09/28
19:07
09/28/20
19:07
ASND

Ascendis Pharma

$151.83 /

-2.2 (-1.43%)

Ascendis Pharma announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ASND Ascendis Pharma
$151.83 /

-2.2 (-1.43%)

ASND Ascendis Pharma
$151.83 /

-2.2 (-1.43%)

09/14/20 JPMorgan
Ascendis Pharma resumed with an Overweight at JPMorgan
08/31/20 Cantor Fitzgerald
Cantor says Ascendis has important catalyst coming with TransCon PTH data
05/20/20 Credit Suisse
Ascendis Pharma price target raised to $154 from $149 at Credit Suisse
05/20/20 Oppenheimer
Ascendis Pharma price target lowered to $208 from $219 at Oppenheimer
ASND Ascendis Pharma
$151.83 /

-2.2 (-1.43%)

  • 08
    Jul
ASND Ascendis Pharma
$151.83 /

-2.2 (-1.43%)

General News
Pelosi says Democrats introducing new COVID-19 relief package » 18:59
09/28/20
09/28
18:59
09/28/20
18:59
SPY

SPDR S&P 500 ETF Trust

$334.20 /

+5.51 (+1.68%)

, SPX

S&P 500

$0.00 /

+ (+0.00%)

According to a statement…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SPY SPDR S&P 500 ETF Trust
$334.20 /

+5.51 (+1.68%)

SPX S&P 500
$0.00 /

+ (+0.00%)

SPY SPDR S&P 500 ETF Trust
$334.20 /

+5.51 (+1.68%)

09/01/20
Fed's Brainard says monetary policy to pivot from stabilization to accommodation
08/17/20 Goldman Sachs
Goldman boosts end of 2020 S&P 500 target to 3,600 from 3,000
06/04/20 Keefe Bruyette
Mattis rebuke 'wake up call' for stock market, says Keefe Bruyette
03/11/20 Goldman Sachs
Goldman Sachs believes the S&P 500 bull market will soon end
SPX S&P 500
$0.00 /

+ (+0.00%)

09/01/20
Fed's Brainard says monetary policy to pivot from stabilization to accommodation
08/17/20 Goldman Sachs
Goldman boosts end of 2020 S&P 500 target to 3,600 from 3,000
06/04/20 Keefe Bruyette
Mattis rebuke 'wake up call' for stock market, says Keefe Bruyette
03/11/20 Goldman Sachs
Goldman Sachs believes the S&P 500 bull market will soon end
SPY SPDR S&P 500 ETF Trust
$334.20 /

+5.51 (+1.68%)

SPX S&P 500
$0.00 /

+ (+0.00%)

SPY SPDR S&P 500 ETF Trust
$334.20 /

+5.51 (+1.68%)

SPX S&P 500
$0.00 /

+ (+0.00%)

SPY SPDR S&P 500 ETF Trust
$334.20 /

+5.51 (+1.68%)

SPX S&P 500
$0.00 /

+ (+0.00%)

SPY SPDR S&P 500 ETF Trust
$334.20 /

+5.51 (+1.68%)

SPX S&P 500
$0.00 /

+ (+0.00%)

Hot Stocks
Boeing awarded $249M Missile Defense Agency contract modification » 18:35
09/28/20
09/28
18:35
09/28/20
18:35
BA

Boeing

$166.20 /

+10.13 (+6.49%)

Boeing was awarded a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BA Boeing
$166.20 /

+10.13 (+6.49%)

BA Boeing
$166.20 /

+10.13 (+6.49%)

09:53 Today
Fly Intel: Top five analyst upgrades
08:46 Today Alembic Global
Alembic upgrades Boeing with 737 MAX return 'finally in sight'
08:27 Today Alembic Global
Boeing upgraded to Overweight from Neutral at Alembic Global
09/24/20 Wolfe Research
Boeing upgraded to Peer Perform from Underperform at Wolfe Research
BA Boeing
$166.20 /

+10.13 (+6.49%)

BA Boeing
$166.20 /

+10.13 (+6.49%)

BA Boeing
$166.20 /

+10.13 (+6.49%)

BA Boeing
$166.20 /

+10.13 (+6.49%)

Hot Stocks
Cable One to acquire 45% minority stake in MBI for about $574.1M in cash » 18:32
09/28/20
09/28
18:32
09/28/20
18:32
CABO

Cable One

$1,755.00 /

+24.06 (+1.39%)

Mega Broadband…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CABO Cable One
$1,755.00 /

+24.06 (+1.39%)

CABO Cable One
$1,755.00 /

+24.06 (+1.39%)

08/11/20 Truist
Cable One price target raised to $2,000 from $1,850 at Truist
05/12/20 KeyBanc
Cable One price target raised to $2,105 from $1,968 at KeyBanc
05/12/20 SunTrust
Cable One price target raised to $1,850 from $1,600 at SunTrust
04/20/20 Cowen
Cable One initiated with a Market Perform at Cowen
CABO Cable One
$1,755.00 /

+24.06 (+1.39%)

  • 20
    May
Hot Stocks
Honeywell awarded $258.66M Army contract » 18:31
09/28/20
09/28
18:31
09/28/20
18:31
HON

Honeywell

$164.42 /

+2.87 (+1.78%)

Honeywell was awarded a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HON Honeywell
$164.42 /

+2.87 (+1.78%)

HON Honeywell
$164.42 /

+2.87 (+1.78%)

08/11/20 RBC Capital
Honeywell downgraded to Sector Perform from Outperform at RBC Capital
08/11/20 RBC Capital
Honeywell downgraded to Sector Perform from Outperform at RBC Capital
07/28/20 Argus
Honeywell price target raised to $165 at Argus on continued product diversity
07/27/20 JPMorgan
Honeywell price target raised to $185 from $177 at JPMorgan
HON Honeywell
$164.42 /

+2.87 (+1.78%)

HON Honeywell
$164.42 /

+2.87 (+1.78%)

HON Honeywell
$164.42 /

+2.87 (+1.78%)

HON Honeywell
$164.42 /

+2.87 (+1.78%)

Hot Stocks
Raytheon Technologies awarded $398.33M Army contract modification » 18:29
09/28/20
09/28
18:29
09/28/20
18:29
RTX

Raytheon Technologies

$58.90 /

+1.41 (+2.45%)

Raytheon Technologies was…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RTX Raytheon Technologies
$58.90 /

+1.41 (+2.45%)

RTX Raytheon Technologies
$58.90 /

+1.41 (+2.45%)

09/20/20 Goldman Sachs
Lockheed Martin downgraded to Buy from Conviction Buy at Goldman Sachs
09/20/20 Goldman Sachs
Raytheon upgraded to Conviction Buy from Buy at Goldman Sachs
09/08/20 Morgan Stanley
Raytheon Technologies initiated with an Overweight at Morgan Stanley
07/29/20 Argus
Raytheon Technologies downgraded to Hold from Buy at Argus
RTX Raytheon Technologies
$58.90 /

+1.41 (+2.45%)

RTX Raytheon Technologies
$58.90 /

+1.41 (+2.45%)

RTX Raytheon Technologies
$58.90 /

+1.41 (+2.45%)

RTX Raytheon Technologies
$58.90 /

+1.41 (+2.45%)

On The Fly
Fly Intel: After-Hours Movers » 18:27
09/28/20
09/28
18:27
09/28/20
18:27
FLUX

Flux Power

$5.45 /

+0.05 (+0.93%)

, RLGT

Radiant Logistics

$5.23 /

+0.16 (+3.16%)

, DNLI

Denali Therapeutics

$35.27 /

+0.14 (+0.40%)

, DYN

Dyne Therapeutics

$21.49 /

-0.52 (-2.36%)

, SNOW

Snowflake

$250.29 /

+21.06 (+9.19%)

, UNFI

United Natural Foods

$19.13 /

+1.235 (+6.90%)

, BEAM

Beam Therapeutics

$26.87 /

+0.14 (+0.52%)

Check out this evening's…

ShowHide Related Items >><<
FLUX Flux Power
$5.45 /

+0.05 (+0.93%)

RLGT Radiant Logistics
$5.23 /

+0.16 (+3.16%)

DNLI Denali Therapeutics
$35.27 /

+0.14 (+0.40%)

DYN Dyne Therapeutics
$21.49 /

-0.52 (-2.36%)

SNOW Snowflake
$250.29 /

+21.06 (+9.19%)

UNFI United Natural Foods
$19.13 /

+1.235 (+6.90%)

BEAM Beam Therapeutics
$26.87 /

+0.14 (+0.52%)

FLUX Flux Power
$5.45 /

+0.05 (+0.93%)

RLGT Radiant Logistics
$5.23 /

+0.16 (+3.16%)

05/12/20 Lake Street
Radiant Logistics price target lowered to $7 from $9 at Lake Street
02/28/20 Benchmark
Radiant Logistics initiated with a Buy at Benchmark
DNLI Denali Therapeutics
$35.27 /

+0.14 (+0.40%)

09/14/20 JPMorgan
Denali Therapeutics resumed with an Overweight at JPMorgan
08/20/20 H.C. Wainwright
Denali Therapeutics price target raised to $45 from $28 at H.C. Wainwright
08/06/20 Goldman Sachs
Denali's LRRK2 program complementary to Biogen's PD pipeline, says Goldman Sachs
08/06/20 Wells Fargo
Biogen 'doubling down on LRRK2' via deal with Denali, says Wells Fargo
DYN Dyne Therapeutics
$21.49 /

-0.52 (-2.36%)

SNOW Snowflake
$250.29 /

+21.06 (+9.19%)

09/21/20
Fly Intel: Top five analyst initiations
09/21/20 Summit Insights
Snowflake initiated with a Sell at Summit Insights
09/21/20 Summit Insights
Snowflake initiated with a Sell at Summit Insights
UNFI United Natural Foods
$19.13 /

+1.235 (+6.90%)

09/23/20 Northcoast
United Natural Foods upgraded to Buy from Neutral at Northcoast
07/30/20 MKM Partners
United Natural Foods initiated with a Buy at MKM Partners
07/29/20 MKM Partners
United Natural Foods initiated with a Buy at MKM Partners
07/16/20 BTIG
United Natural Foods initiated with a Neutral at BTIG
BEAM Beam Therapeutics
$26.87 /

+0.14 (+0.52%)

08/05/20
Fly Intel: Top five analyst initiations
08/05/20 William Blair
Beam Therapeutics initiated with an Outperform at William Blair
03/02/20
Fly Intel: Top five analyst initiations
03/02/20 Wedbush
Wedbush bullish on Beam Therapeutics, initiates with an Outperform
FLUX Flux Power
$5.45 /

+0.05 (+0.93%)

RLGT Radiant Logistics
$5.23 /

+0.16 (+3.16%)

DNLI Denali Therapeutics
$35.27 /

+0.14 (+0.40%)

UNFI United Natural Foods
$19.13 /

+1.235 (+6.90%)

BEAM Beam Therapeutics
$26.87 /

+0.14 (+0.52%)

  • 01
    Oct
  • 17
    Sep
  • 16
    Sep
  • 06
    Feb
  • 29
    Jan
SNOW Snowflake
$250.29 /

+21.06 (+9.19%)

BEAM Beam Therapeutics
$26.87 /

+0.14 (+0.52%)

DNLI Denali Therapeutics
$35.27 /

+0.14 (+0.40%)

DYN Dyne Therapeutics
$21.49 /

-0.52 (-2.36%)

SNOW Snowflake
$250.29 /

+21.06 (+9.19%)

UNFI United Natural Foods
$19.13 /

+1.235 (+6.90%)

SNOW Snowflake
$250.29 /

+21.06 (+9.19%)

UNFI United Natural Foods
$19.13 /

+1.235 (+6.90%)

Hot Stocks
General Dynamics awarded $215.66M Navy contract modification » 18:27
09/28/20
09/28
18:27
09/28/20
18:27
GD

General Dynamics

$140.76 /

+2.495 (+1.80%)

General Dynamics was…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GD General Dynamics
$140.76 /

+2.495 (+1.80%)

GD General Dynamics
$140.76 /

+2.495 (+1.80%)

09/17/20
Fly Intel: Top five analyst downgrades
09/17/20 Goldman Sachs
General Dynamics downgraded to Sell from Buy at Goldman Sachs
09/08/20 Morgan Stanley
General Dynamics initiated with an Underweight at Morgan Stanley
08/03/20
Fly Intel: Top five analyst downgrades
GD General Dynamics
$140.76 /

+2.495 (+1.80%)

GD General Dynamics
$140.76 /

+2.495 (+1.80%)

GD General Dynamics
$140.76 /

+2.495 (+1.80%)

GD General Dynamics
$140.76 /

+2.495 (+1.80%)

Hot Stocks
Lockheed Martin awarded $709.79M Navy contract modification » 18:24
09/28/20
09/28
18:24
09/28/20
18:24
LMT

Lockheed Martin

$390.46 /

+3.6 (+0.93%)

Lockheed Martin was…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LMT Lockheed Martin
$390.46 /

+3.6 (+0.93%)

LMT Lockheed Martin
$390.46 /

+3.6 (+0.93%)

09/20/20 Goldman Sachs
Lockheed Martin downgraded to Buy from Conviction Buy at Goldman Sachs
09/08/20 Morgan Stanley
Lockheed Martin initiated with an Overweight at Morgan Stanley
07/24/20 Argus
Lockheed Martin price target raised to $450 from $425 at Argus
07/17/20 RBC Capital
Lockheed Martin price target lowered to $404 from $410 at RBC Capital
LMT Lockheed Martin
$390.46 /

+3.6 (+0.93%)

LMT Lockheed Martin
$390.46 /

+3.6 (+0.93%)

LMT Lockheed Martin
$390.46 /

+3.6 (+0.93%)

Hot Stocks
Quidel supports Trump administration's plans for school COVID-19 testing » 18:13
09/28/20
09/28
18:13
09/28/20
18:13
QDEL

Quidel

$198.32 /

+1.28 (+0.65%)

, ABT

Abbott

$104.48 /

+1.04 (+1.01%)

Quidel Corporation (QDEL)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
QDEL Quidel
$198.32 /

+1.28 (+0.65%)

ABT Abbott
$104.48 /

+1.04 (+1.01%)

QDEL Quidel
$198.32 /

+1.28 (+0.65%)

08/28/20 Piper Sandler
COVID-19 test provider selloff on Abbott approval overdone, says Piper
08/28/20 Piper Sandler
Quidel pullback on Abbott approval a buying opportunity, says Piper Sandler
08/27/20 Piper Sandler
Piper says medical diagnostics stocks oversold on Abbott COVID-19 test news
08/27/20 Goldman Sachs
Abbott test's sensitivity, low price 'positive surprises,' says Goldman Sachs
ABT Abbott
$104.48 /

+1.04 (+1.01%)

13:34 Today Stifel
Libre 3 CE Mark approval a 'positive surprise' for Abbott, says Stifel
10:51 Today Piper Sandler
Piper says DexCom's coming G7 introduction important as Abbott narrows gap
09/11/20 Wolfe Research
Abbott initiated with an Outperform at Wolfe Research
08/31/20 Credit Suisse
Abbott price target raised to $136 from $109 at Credit Suisse
QDEL Quidel
$198.32 /

+1.28 (+0.65%)

ABT Abbott
$104.48 /

+1.04 (+1.01%)

QDEL Quidel
$198.32 /

+1.28 (+0.65%)

ABT Abbott
$104.48 /

+1.04 (+1.01%)

QDEL Quidel
$198.32 /

+1.28 (+0.65%)

ABT Abbott
$104.48 /

+1.04 (+1.01%)

ABT Abbott
$104.48 /

+1.04 (+1.01%)

Hot Stocks
Maxeon Solar files patent infringement suit against Canadian Solar in Japan » 18:08
09/28/20
09/28
18:08
09/28/20
18:08
MAXN

Maxeon Solar

$16.18 /

+1.91 (+13.38%)

, CSIQ

Canadian Solar

$34.01 /

+1.82 (+5.65%)

Maxeon Solar (MAXN)…

Maxeon Solar (MAXN) announced that it filed a patent infringement lawsuit against Canadian Solar Japan K.K., in Tokyo District Court, Japan. The lawsuit filing alleges Canadian Solar Japan infringes Maxeon's Japan Patent No. JP6642841B2 for the proprietary and fundamental shingled solar cell panel technology used to deploy solar panels that Maxeon designs, manufactures and sells under the 'SunPower Performance' brand name. Canadian Solar Japan is a wholly owned subsidiary of Canadian Solar (CSIQ), which is headquartered in Canada with operations and production facilities in China and in South-East Asia.

ShowHide Related Items >><<
MAXN Maxeon Solar
$16.18 /

+1.91 (+13.38%)

CSIQ Canadian Solar
$34.01 /

+1.82 (+5.65%)

MAXN Maxeon Solar
$16.18 /

+1.91 (+13.38%)

09/11/20 Baird
Baird upgrades 'simpler' SunPower to Outperform with $13 target
09/03/20 Raymond James
Maxeon Solar initiated with a Market Perform at Raymond James
08/28/20
Fly Intel: Top five analyst initiations
08/27/20 Goldman Sachs
Maxeon Solar initiated with a Neutral at Goldman Sachs
CSIQ Canadian Solar
$34.01 /

+1.82 (+5.65%)

08/27/20 GLJ Research
Canadian Solar initiated with a Strong Buy at GLJ Research
07/20/20 Roth Capital
Roth boosts Daqo target to $120 after polysilicon facility explosion reports
03/25/20 Roth Capital
ITC extension 'NOT' in Phase 3 coronavirus rescue package, says Roth Capital
10/07/19 Goldman Sachs
Goldman says U.S. solar makers should benefit from end of bifacial exemption
CSIQ Canadian Solar
$34.01 /

+1.82 (+5.65%)

CSIQ Canadian Solar
$34.01 /

+1.82 (+5.65%)

MAXN Maxeon Solar
$16.18 /

+1.91 (+13.38%)

CSIQ Canadian Solar
$34.01 /

+1.82 (+5.65%)

MAXN Maxeon Solar
$16.18 /

+1.91 (+13.38%)

CSIQ Canadian Solar
$34.01 /

+1.82 (+5.65%)

Periodicals
House lawmakers unveil plan to revise FAA jet approvals, Bloomberg reports » 17:55
09/28/20
09/28
17:55
09/28/20
17:55
BA

Boeing

$166.20 /

+10.13 (+6.49%)

A bipartisan bill…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BA Boeing
$166.20 /

+10.13 (+6.49%)

BA Boeing
$166.20 /

+10.13 (+6.49%)

09:53 Today
Fly Intel: Top five analyst upgrades
08:46 Today Alembic Global
Alembic upgrades Boeing with 737 MAX return 'finally in sight'
08:27 Today Alembic Global
Boeing upgraded to Overweight from Neutral at Alembic Global
09/24/20 Wolfe Research
Boeing upgraded to Peer Perform from Underperform at Wolfe Research
BA Boeing
$166.20 /

+10.13 (+6.49%)

BA Boeing
$166.20 /

+10.13 (+6.49%)

BA Boeing
$166.20 /

+10.13 (+6.49%)

BA Boeing
$166.20 /

+10.13 (+6.49%)

Periodicals
Petrobras plans to spend $6B through 2024 to decommission assets, Reuters says » 17:46
09/28/20
09/28
17:46
09/28/20
17:46
PBR

Petrobras

$7.20 /

-0.26 (-3.49%)

Petrobras said it intends…

Petrobras said it intends to spend $6B through 2024 to decommission 18 offshore platforms, underwater gas pipelines, and offshore wells, Reuters' Sabrina Valle reports. In a presentation filed to the securities regulator, Brazil's state-controlled oil producer said it anticipates proceeds of $1B from divestments in 2020, after receiving $14.4B from asset sales last year, Valle notes. Reference Link

ShowHide Related Items >><<
PBR Petrobras
$7.20 /

-0.26 (-3.49%)

PBR Petrobras
$7.20 /

-0.26 (-3.49%)

05/18/20 Raymond James
Petrobras downgraded to Underperform from Market Perform at Raymond James
05/18/20 Raymond James
Petrobras downgraded to Underperform from Market Perform at Raymond James
05/14/20 BofA
Petrobras downgraded to Neutral from Buy at BofA
05/08/20 Bradesco BBI
Petrobras upgraded to Outperform from Neutral at Bradesco
  • 06
    Feb
PBR Petrobras
$7.20 /

-0.26 (-3.49%)

PBR Petrobras
$7.20 /

-0.26 (-3.49%)

Hot Stocks
Ballard Power expanding manufacturing capacity for production of MEAs » 17:31
09/28/20
09/28
17:31
09/28/20
17:31
BLDP

Ballard Power

$14.91 /

+0.645 (+4.52%)

Ballard Power announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BLDP Ballard Power
$14.91 /

+0.645 (+4.52%)

BLDP Ballard Power
$14.91 /

+0.645 (+4.52%)

08/24/20
Fly Intel: Top five analyst initiations
08/24/20 Bernstein
Bernstein starts Ballard at Outperform as pure play on hydrogen economy
08/24/20 Bernstein
Ballard Power initiated with an Outperform at Bernstein
08/21/20 Roth Capital
Roth Capital checks show 'material catalyst' is near for Ballard Power
BLDP Ballard Power
$14.91 /

+0.645 (+4.52%)

BLDP Ballard Power
$14.91 /

+0.645 (+4.52%)

BLDP Ballard Power
$14.91 /

+0.645 (+4.52%)

BLDP Ballard Power
$14.91 /

+0.645 (+4.52%)

Conference/Events
Keurig Dr Pepper participates in a conference call with Morgan Stanley » 17:29
09/28/20
09/28
17:29
09/28/20
17:29
KDP

Keurig Dr Pepper

$27.84 /

-0.06 (-0.22%)

Conference call with CEO…

Conference call with CEO Gamgort, CFO Dokmecioglu and Chief of Corporate Affairs will be held on September 29 at 10 am hosted by Morgan Stanley. Webcast Link

ShowHide Related Items >><<
KDP Keurig Dr Pepper
$27.84 /

-0.06 (-0.22%)

KDP Keurig Dr Pepper
$27.84 /

-0.06 (-0.22%)

08/27/20 Jefferies
Keurig Dr Pepper has long runway for pod category growth, says Jefferies
08/26/20
Fly Intel: Top five analyst upgrades
08/26/20 Morgan Stanley
Keurig Dr Pepper upgraded to Overweight on coffee 'boost' at Morgan Stanley
08/26/20 Morgan Stanley
Keurig Dr Pepper upgraded to Overweight from Equal Weight at Morgan Stanley
KDP Keurig Dr Pepper
$27.84 /

-0.06 (-0.22%)

  • 18
    Aug
  • 03
    Aug
  • 21
    May
  • 05
    Mar
KDP Keurig Dr Pepper
$27.84 /

-0.06 (-0.22%)

Hot Stocks
Aziyo Biologics appoints Matthew Ferguson CFO » 17:20
09/28/20
09/28
17:20
09/28/20
17:20
AZYO

Aziyo Biologics

$0.00 /

+ (+0.00%)

Aziyo Biologics announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Hot Stocks
Fiat Chrysler agrees to pay $9.5M penalty for disclosure violations » 17:08
09/28/20
09/28
17:08
09/28/20
17:08
FCAU

Fiat Chrysler

$12.38 /

+0.415 (+3.47%)

The Securities and…

The Securities and Exchange Commission announced that Fiat Chrysler Automobiles agreed to settle charges that it made misleading disclosures about an internal audit of its emissions control systems. The SEC's order found that in February 2016, FCA represented in both a press release and an annual report that it conducted an internal audit which confirmed that FCA's vehicles complied with environmental regulations concerning emissions. As found in the order, FCA's statements did not sufficiently disclose the limited scope of its internal audit, which focused only on finding a specific type of defeat device, or that the audit was not a comprehensive review of FCA's compliance with U.S. emissions regulations. In addition, at the time FCA made these statements, engineers at the U.S. Environmental Protection Agency, EPA, and California Air Resource Board, CARB, had raised concerns to FCA about the emissions systems in certain of its diesel vehicles. "This case demonstrates the importance of public companies providing accurate and complete information to investors," said Joel R. Levin, Regional Director of the SEC's Chicago Regional Office. "At a time of heightened scrutiny of automakers' regulatory compliance, FCA provided misleading assurances to investors by not disclosing the limitations of its internal audit." The SEC's order found that FCA violated the reporting provisions of the federal securities laws. Without admitting or denying the SEC's findings, FCA agreed to cease and desist from committing violations of these provisions and to pay a $9.5M civil penalty. Reference Link

ShowHide Related Items >><<
FCAU Fiat Chrysler
$12.38 /

+0.415 (+3.47%)

FCAU Fiat Chrysler
$12.38 /

+0.415 (+3.47%)

09/08/20 Bernstein
Fiat Chrysler initiated with an Underperform at Bernstein
08/04/20 Jefferies
Ford, FCA price targets raised at Jefferies following earnings
06/30/20 UBS
Fiat Chrysler price target raised to EUR 9 from EUR 6 at UBS
06/25/20 Morgan Stanley
Talks with Ford dealer highlight inventory risk, says Morgan Stanley
FCAU Fiat Chrysler
$12.38 /

+0.415 (+3.47%)

FCAU Fiat Chrysler
$12.38 /

+0.415 (+3.47%)

FCAU Fiat Chrysler
$12.38 /

+0.415 (+3.47%)

FCAU Fiat Chrysler
$12.38 /

+0.415 (+3.47%)

Upgrade
AP Moller Maersk upgraded to Buy from Neutral at Goldman Sachs » 16:59
09/28/20
09/28
16:59
09/28/20
16:59
AMKBY

AP Moller Maersk

$0.00 /

+ (+0.00%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AMKBY AP Moller Maersk
$0.00 /

+ (+0.00%)

09/22/20 JPMorgan
AP Moller Maersk upgraded to Overweight from Neutral at JPMorgan
08/21/20 JPMorgan
AP Moller Maersk downgraded to Neutral from Overweight at JPMorgan
08/20/20 Barclays
AP Moller Maersk price target raised to DKK 8,100 from DKK 6,400 at Barclays
08/20/20 Credit Suisse
AP Moller Maersk price target raised to DKK 11,279 at Credit Suisse
AMKBY AP Moller Maersk
$0.00 /

+ (+0.00%)

Hot Stocks
United Natural Foods reports Q4 gross margin 14.81% vs. 14.4% a year ago » 16:58
09/28/20
09/28
16:58
09/28/20
16:58
UNFI

United Natural Foods

$19.13 /

+1.235 (+6.90%)

Gross margin rate in the…

Gross margin rate in the fourth quarter was 14.81% of net sales compared to 14.40% of net sales for the fourth quarter of fiscal 2019. Retail contributed approximately 29 basis points of the increase due to a higher gross margin rate driven by lower promotional spending and the retail segment representing a greater percentage of total net sales. Wholesale contributed the remaining 12 basis points of the increase primarily due to lower inbound freight expense and a lower LIFO charge.

ShowHide Related Items >><<
UNFI United Natural Foods
$19.13 /

+1.235 (+6.90%)

UNFI United Natural Foods
$19.13 /

+1.235 (+6.90%)

09/23/20 Northcoast
United Natural Foods upgraded to Buy from Neutral at Northcoast
07/30/20 MKM Partners
United Natural Foods initiated with a Buy at MKM Partners
07/29/20 MKM Partners
United Natural Foods initiated with a Buy at MKM Partners
07/16/20 BTIG
United Natural Foods initiated with a Neutral at BTIG
UNFI United Natural Foods
$19.13 /

+1.235 (+6.90%)

UNFI United Natural Foods
$19.13 /

+1.235 (+6.90%)

UNFI United Natural Foods
$19.13 /

+1.235 (+6.90%)

Hot Stocks
Altimeter Capital reports 13.3% passive stake in Snowflake » 16:56
09/28/20
09/28
16:56
09/28/20
16:56
SNOW

Snowflake

$250.29 /

+21.06 (+9.19%)

Altimeter Capital…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SNOW Snowflake
$250.29 /

+21.06 (+9.19%)

SNOW Snowflake
$250.29 /

+21.06 (+9.19%)

09/21/20
Fly Intel: Top five analyst initiations
09/21/20
Snowflake initiated with a Sell at Summit Insights
09/21/20 Summit Insights
Snowflake initiated with a Sell at Summit Insights
  • 16
    Sep
SNOW Snowflake
$250.29 /

+21.06 (+9.19%)

SNOW Snowflake
$250.29 /

+21.06 (+9.19%)

SNOW Snowflake
$250.29 /

+21.06 (+9.19%)

Hot Stocks
FDA approves Pfizer's XELJANZ for treatment of pcJIA » 16:55
09/28/20
09/28
16:55
09/28/20
16:55
PFE

Pfizer

$36.41 /

+0.35 (+0.97%)

Pfizer announced that the…

Pfizer announced that the U.S. Food and Drug Administration approved XELJANZ for the treatment of children and adolescents 2 years and older with active polyarticular course juvenile idiopathic arthritis. Two formulations were approved, a tablet and an oral solution, and are dosed based upon weight. This approval makes XELJANZ the first and only Janus kinase inhibitor approved in the U.S. for the treatment of pcJIA. "Polyarticular course juvenile idiopathic arthritis, or pcJIA, is debilitating as it can cause significant joint pain and limit participation in child appropriate activities," said Dr. Hermine Brunner, Director of the Division of Rheumatology at Cincinnati Children's Hospital Medical Center and Scientific Director of the Pediatric Rheumatology Collaborative Study Group. "Although there are already several advanced treatments available, tofacitinib will be an appealing new option given it does not require injections or infusions. These can be quite burdensome to both children with pcJIA and their caretakers. The FDA approval of Xeljanz for pcJIA is positive news for this community as it provides a new advanced treatment option in an oral formulation."

ShowHide Related Items >><<
PFE Pfizer
$36.41 /

+0.35 (+0.97%)

PFE Pfizer
$36.41 /

+0.35 (+0.97%)

09/21/20 Morgan Stanley
Eli Lilly's Verzenio 'clear winner' over Pfizer's Ibrance, says Morgan Stanley
09/16/20 Baird
uniQure weakness a buying opportunity, says Baird
09/15/20 Citi
Sarepta price target raised to $190 from $177 at Citi
09/09/20 SVB Leerink
AstraZeneca pause 'a mixed blessing for Moderna, others, says SVB Leerink
PFE Pfizer
$36.41 /

+0.35 (+0.97%)

PFE Pfizer
$36.41 /

+0.35 (+0.97%)

PFE Pfizer
$36.41 /

+0.35 (+0.97%)

PFE Pfizer
$36.41 /

+0.35 (+0.97%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.